This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bull Takes Big Dose of Spectrum Pharma

By Mike Yamamoto, managing editor of OptionMonster

NEW YORK -- Spectrum Pharmaceuticals (SPPI) has lost a quarter of its value in the last three weeks, but now the bulls are back.

OptionMonster's tracking systems detected the purchase of 3,500 November 16 calls for 45 cents at the same second in the final hour of trading Tuesday. This is clearly new buying, as open interest in the strike was only 749 contracts at the beginning of the day.

The stock fell 3.24% to end the session at $12.23. The hematology and oncology drug developer gapped lower on Aug. 8 after reporting quarterly results even though it beat earnings and revenue forecasts.

If Tuesday's long calls are held until they expire in mid-November, the stock would need to be above $16.45 at that time for the options to be profitable --a level seen just three weeks ago. Premiums on those contracts could also increase well before expiration if the shares rise by lesser margins, providing an opportunity to sell the calls with gains sooner.

The trading pushed overall option volume in the name to nearly double its daily average. Calls outnumbered puts by 3 to 1, a reflection of the bullish sentiment.

Yamamoto has no positions in SPPI.

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $126.99 -0.48%
FB $84.09 1.20%
GOOG $535.72 0.06%
TSLA $206.30 0.50%
YHOO $44.90 0.55%

Markets

DOW 17,997.93 -37.00 -0.21%
S&P 500 2,103.76 +3.36 0.16%
NASDAQ 5,018.0050 +23.4030 0.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs